858 Results

People

  1. Cheung
    Cheung
  2. Kushner
    Kushner
  3. Modak
    Modak
  4. Kramer
    Kramer
  5. Larson
    Larson
  6. Roberts
    Roberts
  7. Basu
    Basu
  8. La Quaglia
    La Quaglia
  9. Cheung
    Cheung
  10. Wolden
    Wolden

Groups

  1. Neuroblastoma Service (858)
  2. Pediatrics, Department of (858)
  3. GSK Faculty (682)
  4. Tow Center for Developmental Oncology (TCDO) (677)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (650)
  6. Center for Molecular Imaging and Biotechnology (427)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (242)
  8. Center for Hematologic Malignancies (225)
  9. Neuro-Oncology Service (199)
  10. Pediatric Leukemia (174)
  1. "Neuroblastoma Service"
Formats
  1. Journal Article (509)
  2. Meeting Abstract (295)
  3. Review (17)
  4. Book Section (14)
  5. Conference Paper (14)
  6. Editorial (5)
  7. Correspondence (2)
  8. Book Whole (1)
  9. Guidelines (1)
Groups
  1. Neuroblastoma Service (858)
  2. Pediatrics, Department of (858)
  3. GSK Faculty (682)
  4. Tow Center for Developmental Oncology (TCDO) (677)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (650)
  6. Center for Molecular Imaging and Biotechnology (427)

More Groups

People
  1. Nai-Kong Cheung (648)
  2. Brian Kushner (311)
  3. Shakeel Modak (249)
  4. Kim Kramer (176)
  5. Steven Larson (109)
  6. Stephen Roberts (107)

More People

Years
  1. 2025 (10)
  2. 2024 (26)
  3. 2023 (36)
  4. 2022 (44)
  5. 2021 (41)
  6. 2020 (49)

More Years

Publications
  1. Pediatric Blood and Cancer (115)
  2. Journal of Clinical Oncology (98)
  3. Cancer Research (41)
  4. Journal of Nuclear Medicine (36)
  5. Neuro-Oncology (32)
  6. Clinical Cancer Research (27)

More Publications

Publishers
  1. Wiley Periodicals, Inc (119)
  2. American Association for Cancer Research (102)
  3. American Society of Clinical Oncology (101)
  4. Elsevier Inc. (55)
  5. Oxford University Press (42)
  6. Society of Nuclear Medicine (36)

More Publishers

Results (858)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and updated safety results from pivotal phase II trial 201 of naxitamab (Hu3F8): A humanized GD2-targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)
    Meeting Abstract

    Mora, J.; Chan, G. C.; Morgenstern, D. A.; Nysom, K.; Bear, M.; Worsaae Dalby, L.; Lisby, S.; Kushner, B. H.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Pivotal trial 201 data on outpatient administration of naxitamab (Hu3F8), a humanized GD2 targeted immunotherapy for the treatment of refractory/relapsed (R/R) high-risk (HR) neuroblastoma (NB)
    Meeting Abstract

    Morgenstern, D. A.; Mora, J.; Chan, G. C.; Nysom, K.; Bear, M.; Worsaae Dalby, L.; Lisby, S.; Kushner, B. H.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • B7H3-directed intraperitoneal radioimmunotherapy with radioiodinated omburtamab for desmoplastic small round cell tumor and other peritoneal tumors: Results of a phase I study
    Journal Article

    Modak, S.; Zanzonico, P.; Grkovski, M.; Slotkin, E. K.; Carrasquillo, J. A.; Lyashchenko, S. K.; Lewis, J. S.; Cheung, I. Y.; Heaton, T.; LaQuaglia, M. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Reactive regional lymphadenopathy associated with neuroblastoma immunotherapy
    Meeting Abstract

    Lentini-Rivera, A.; Kushner, B.; Modak, S.; Price, A.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • International, multicenter phase II trial with humanized anti-GD2 monoclonal antibody naxitamab for treatment of refractory/relapsed high-risk neuroblastoma: Efficacy and safety data
    Meeting Abstract

    Mora, J.; Chan, G.; Morgenstern, D.; Nysom, K.; Bear, M.; Dalby, L. W.; Lisby, S.; Kushner, B.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Updated entrectinib data from a phase 1/2 trial in children and adolescents with recurrent or refractory solid tumors, including primary central nervous system (CNS) tumors
    Meeting Abstract

    Desai, A. V.; Robinson, G. W.; Basu, E. M.; Foster, J.; Gauvain, K.; Sabnis, A. J.; Macy, M. E.; Maese, L.; Yoon, J.; Cash, T.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Surveillance for early detection of neuroblastoma central nervous system relapse
    Meeting Abstract

    Modak, S.; Kushner, B.; Cheung, N. K.; Kramer, K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Telemedicine blood pressure monitoring after anti-GD2 monoclonal antibody immunotherapy during the COVID-19 pandemic
    Meeting Abstract

    Glincher, R.; Cheung, N. K.; Kasper, C.; Scoppetuolo, L. A.; Modak, S.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • COVID-19 in pediatric hematology and oncology patients in New York City
    Meeting Abstract

    Gampel, B.; Troullioud Lucas, A.; Broglie, L.; Gartrell-Corrado, R.; Lee, M.; Levine, J.; Orjuela-Grimm, M.; Satwani, P.; Glade Bender, J.; Roberts, S.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save